Patents by Inventor Sampath K. Anandan

Sampath K. Anandan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7772245
    Abstract: Disclosed are compounds of formula I that inhibit histone deacetylase (HDAC) enzymatic activity, pharmaceutical compositions comprising such compounds, as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC, wherein A, W, W1, W2, Ar2, and G are described herein.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 10, 2010
    Assignee: Miikana Therapeutics, Inc.
    Inventors: Sampath K. Anandan, Xiao-Yi Xiao, John S. Ward, Dinesh V. Patel
  • Publication number: 20080139535
    Abstract: Disclosed are compounds which inhibit histone deacetylase (HDAC) enzymatic activity. Also disclosed are pharmaceutical compositions comprising such compounds as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC.
    Type: Application
    Filed: January 24, 2008
    Publication date: June 12, 2008
    Inventors: Sampath K. Anandan, Xiao-Yi Xiao, Dinesh V. Patel, John S. Ward
  • Patent number: 7361743
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including Gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: April 22, 2008
    Assignee: Pfizer Inc
    Inventors: Jason G. Lewis, Sampath K Anandan, Hardwin O'Dowd, Mikhail F Gordeev, Liansheng Li
  • Patent number: 7345043
    Abstract: Disclosed are compounds which inhibit histone deacetylase (HDAC) enzymatic activity. Also disclosed are pharmaceutical compositions comprising such compounds as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: March 18, 2008
    Assignee: Miikana Therapeutics
    Inventors: Sampath K. Anandan, Xiao-Yi Xiao, Dinesh V. Patel, John Ward
  • Patent number: 7256177
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including Gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Grant
    Filed: November 17, 2004
    Date of Patent: August 14, 2007
    Assignee: Vicuron Pharmaceuticals, Inc.
    Inventors: Jason G. Lewis, Sampath K. Anandan, Hardwin O'Dowd, Mikhail F. Gordeev
  • Patent number: 7164011
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against bacteria, including gram positive organisms, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: January 16, 2007
    Assignee: Vicuron Pharmaceuticals, Inc.
    Inventors: Jason Lewis, Dinesh V. Patel, Sampath K. Anandan, Mikhail F. Gordeev
  • Publication number: 20040116690
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against bacteria, including gram positive organisms, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Application
    Filed: August 15, 2003
    Publication date: June 17, 2004
    Inventors: Jason Lewis, Dinesh V. Patel, Sampath K. Anandan, Mikhail F. Gordeev